Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;

Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population Carlos Almonacid-Sánchez; Borja G. Cosío; Andrea Trisán-Alonso; Francisco Javier Callejas-González; Carolina Cisneros; Eva Martínez-Moragón; Vicente Plaza Moral; Elisabeth Vera; José Gregorio Soto-Campos; Carlos Martínez-Rivera; Bernardino Alcazar-Navarrete; Isabel Urrutia Landa; Juan Luis García-Rivero; Alicia Padilla Galo; Francisco Álvarez-Gutierrez; Jacinto Ramos-González; José Ángel Carretero-Gracia; Inmaculada Lluch; Luis Puente; Rubén Andujar-Espinosa; Luis Pérez-de-Llano;

The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort Diana Betancor; Carlos Villalobos-Vilda; José María Olaguibel; José Manuel Rodrigo-Muñoz; María Jose Alvarez Puebla; Ebymar Arismendi; Pilar Barranco; Blanca Barroso; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Elena Curto; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco-Javier González-Barcala; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Cesar Picado; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Marcela Valverde-Monge; Joaquín Sastre;